Secondary sclerosing cholangitis in a young COVID-19 patient resulting in death: A case report

Figure 1 The chart shows the chronological timeline of patient treatment with adjacent changes in laboratory parameters and imaging as well as intensive care unit interventions. MRCP: Magnetic resonance cholangiopancreatography; ERCP: Endoscopic retrograde cholangiopancreatography; SARS-CoV-2: Severe acute respiratory syndrome coronavirus 2.

Figure 2 Imaging throughout the hospital treatment. A: The image shows early contrast enhanced computed tomography of the upper abdomen on day 10 after admission without significant cholangetic stasis or narrowing of the common bile duct (CBD); B: A prepapillary narrowing of the CBD can be identified with at that point suspected CBD stricture (day 47); C: The image shows a rarefication of the peripheral bile ducts indicating early secondary sclerosing cholangitis on day 60; D: The image shows magnetic resonance cholangiopancreatography at day 105 after admission with classical appearance of secondary sclerosing cholangitis.